Literature DB >> 27049557

Interleukin 6 promoter 174 G/C polymorphisms in acute ischemic stroke: G allele is protective but not associated with IL-6 levels or stroke outcome.

J Yan1, Greer Jm1, McCombe Pa2.   

Abstract

Our study investigated the frequency of interleukin-6 (IL-6) promoter polymorphism rs1800795 (-174 G>C), possible association of this polymorphism with IL-6 levels and the outcome after stroke in 95 patients with acute ischemic stroke and 268 healthy subjects. It shows a significant reduction in the frequency of G alleles in stroke patients compared to healthy controls. Carriage of G allele is not associated with stroke subtypes, the initial severity or the outcome after stroke. The -174 polymorphisms were not associated with variation in IL-6 levels post-stroke. Our results indicate that IL-6 promoter -174 polymorphisms may play a role in susceptibility to stroke, but not stroke outcome.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute ischemic stroke; Immunogenetics; Interleukin 6; Polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27049557     DOI: 10.1016/j.jneuroim.2016.02.001

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

1.  The SG13S114 polymorphism of the ALOX5AP gene is associated with ischemic stroke in Europeans: a meta-analysis of 8062 subjects.

Authors:  Zhongjun Chen; Jinyu Zheng; Wenguang Liu; Kun Yang; Kai Li; Baosheng Huang; Ronglan Zhu; Xiaocheng Lu; Lixin Li
Journal:  Neurol Sci       Date:  2017-01-18       Impact factor: 3.307

Review 2.  Influences of genetic variants on stroke recovery: a meta-analysis of the 31,895 cases.

Authors:  Nikhil Math; Thang S Han; Irina Lubomirova; Robert Hill; Paul Bentley; Pankaj Sharma
Journal:  Neurol Sci       Date:  2019-07-29       Impact factor: 3.307

3.  Association of Interleukin-6-174G/C Polymorphism With Ischemic Stroke: An Updated Meta-Analysis.

Authors:  Jie Chai; Xian-Ling Cao; Feng Lu
Journal:  Front Neurol       Date:  2022-01-06       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.